{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:49:56Z","timestamp":1782478196998,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012157","name":"Shanghai Key Discipline Construction Project","doi-asserted-by":"publisher","award":["2024-DFZD-003S"],"award-info":[{"award-number":["2024-DFZD-003S"]}],"id":[{"id":"10.13039\/501100012157","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1466200"],"award-info":[{"award-number":["22ZR1466200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172820"],"award-info":[{"award-number":["82172820"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019978","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canlet.2026.218445","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:14:33Z","timestamp":1774311273000},"page":"218445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma"],"prefix":"10.1016","volume":"649","author":[{"given":"Meng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongjie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-6768","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0605-7273","authenticated-orcid":false,"given":"Chunlong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218445_bib1","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218445_bib2","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.cell.2022.06.033","article-title":"Invasive glioma cells: the malignant pioneers that follow the current","volume":"185","author":"Taylor","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218445_bib3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/d41573-022-00146-7","article-title":"Targeting drug-resistant glioblastoma","volume":"21","author":"Crunkhorn","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.canlet.2026.218445_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202203958","article-title":"Brain Co-Delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy","volume":"34","author":"Zou","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2026.218445_bib5","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41588-021-00927-7","article-title":"Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states","volume":"53","author":"Chaligne","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218445_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.abn7570","article-title":"Mechanism-based design of agents that selectively target drug-resistant glioma","volume":"377","author":"Lin","year":"2022","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.canlet.2026.218445_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","article-title":"m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism","volume":"22","author":"Yue","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218445_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.118.033794","article-title":"FTO-dependent N-Methyladenosine regulates cardiac function during remodeling and repair","volume":"139","author":"Mathiyalagan","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.canlet.2026.218445_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","article-title":"m(6)A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and Cell Proliferation Program","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218445_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41388-021-02146-0","article-title":"The mA reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation","volume":"41","author":"Xu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218445_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA mA methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218445_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/mA\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218445_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/2159-8290.CD-20-0331","article-title":"The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells","volume":"11","author":"Dixit","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218445_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12943-019-1119-7","article-title":"mA mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218445_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-020-20379-7","article-title":"EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma","volume":"12","author":"Fang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218445_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-021-01124-z","article-title":"YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m(6)A modification to activate NF-kappaB and promote the malignant progression of glioma","volume":"14","author":"Chai","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218445_bib17","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1038\/s41467-022-31820-4","article-title":"XPC-PARP complexes engage the chromatin remodeler ALC1 to catalyze global genome DNA damage repair","volume":"13","author":"Blessing","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218445_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/ncb3436","article-title":"SCAI promotes DNA double-strand break repair in distinct chromosomal contexts","volume":"18","author":"Hansen","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218445_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/43932","article-title":"Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination","volume":"401","author":"Johnson","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218445_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004943","article-title":"DNA damage response factors from diverse pathways, including DNA crosslink repair, mediate alternative end joining","volume":"11","author":"Howard","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2026.218445_bib21","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting mA reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218445_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-023-01316-8","article-title":"O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N-methyladenosine-dependent manner","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218445_bib23","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1038\/s41467-022-32963-0","article-title":"Autophagy induction promoted by mA reader YTHDF3 through translation upregulation of FOXO3 mRNA","volume":"13","author":"Hao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218445_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.canlet.2026.218445_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-019-1088-x","article-title":"mA modification suppresses ocular melanoma through modulating HINT2 mRNA translation","volume":"18","author":"Jia","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218445_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218445_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N(6)-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218445_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.08.018","article-title":"Coordinated splicing of regulatory detained introns within oncogenic transcripts creates an exploitable vulnerability in malignant glioma","volume":"32","author":"Braun","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218445_bib29","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1158\/2159-8290.CD-19-0215","article-title":"Targeting glioblastoma stem cells through disruption of the circadian clock","volume":"9","author":"Dong","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218445_bib30","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1038\/s41467-019-11232-7","article-title":"m(6)A modification of a 3' UTR site reduces RME1 mRNA levels to promote meiosis","volume":"10","author":"Bushkin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218445_bib31","doi-asserted-by":"crossref","first-page":"10298","DOI":"10.1093\/nar\/gkt802","article-title":"Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection","volume":"41","author":"Kakarougkas","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218445_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/neuonc\/nor011","article-title":"N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide","volume":"13","author":"Tang","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218445_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-024-02089-6","article-title":"Writers, readers, and erasers RNA modifications and drug resistance in cancer","volume":"23","author":"Chen","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218445_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12943-024-02132-6","article-title":"RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy","volume":"23","author":"Shi","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218445_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-024-01763-x","article-title":"Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis","volume":"9","author":"Yan","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218445_bib36","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1021\/acs.accounts.3c00440","article-title":"N-Methyladenosine mRNA modification: from modification site selectivity to neurological functions","volume":"56","author":"Zhang","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.canlet.2026.218445_bib37","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/cr.2017.99","article-title":"Ythdc2 is an N-methyladenosine binding protein that regulates mammalian spermatogenesis","volume":"27","author":"Hsu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218445_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/cr.2017.10","article-title":"Cytoplasmic mA reader YTHDF3 promotes mRNA translation","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218445_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218445_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","article-title":"YTHDF3 induces the translation of mA-Enriched gene transcripts to promote breast cancer brain metastasis","volume":"38","author":"Chang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218445_bib41","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218445_bib42","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The mA reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218445_bib43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41586-023-06267-2","article-title":"Remote neuronal activity drives glioma progression through SEMA4F","volume":"619","author":"Huang-Hobbs","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218445_bib44","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1158\/0008-5472.CAN-18-0569","article-title":"Replication stress drives constitutive activation of the DNA damage response and radioresistance in glioblastoma stem-like cells","volume":"78","author":"Carruthers","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218445_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41586-023-06635-y","article-title":"Chromatin compartmentalization regulates the response to DNA damage","volume":"623","author":"Arnould","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218445_bib46","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.cell.2023.08.038","article-title":"Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration","volume":"186","author":"Dileep","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218445_bib47","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1126\/science.adh3694","article-title":"RHINO directs MMEJ to repair DNA breaks in mitosis","volume":"381","author":"Brambati","year":"2023","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.canlet.2026.218445_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccell.2019.12.015","article-title":"EZH2 inhibition sensitizes CARM1-High, homologous recombination proficient ovarian cancers to PARP inhibition","volume":"37","author":"Karakashev","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218445_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.020","article-title":"METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-\u03baB to promote the malignant progression of IDH-wildtype glioma","volume":"511","author":"Chang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218445_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-021-02271-9","article-title":"ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism","volume":"22","author":"Tassinari","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2026.218445_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-021-01124-z","article-title":"YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m(6)A modification to activate NF-\u03baB and promote the malignant progression of glioma","volume":"14","author":"Chai","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218445_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40478-020-00941-6","article-title":"RNA modifications in brain tumorigenesis","volume":"8","author":"Huang","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.canlet.2026.218445_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41419-022-04672-5","article-title":"YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218445_bib54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41375-024-02451-z","article-title":"YTHDC1 is a therapeutic target for B-cell acute lymphoblastic leukemia by attenuating DNA damage response through the KMT2C-H3K4me1\/me3 epigenetic axis","volume":"39","author":"Li","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218445_bib55","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1038\/s44318-024-00153-x","article-title":"YTHDC1 m(6)A-dependent and m(6)A-independent functions converge to preserve the DNA damage response","volume":"43","author":"Elvira-Bl\u00e1zquez","year":"2024","journal-title":"Embo j"},{"key":"10.1016\/j.canlet.2026.218445_bib56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41419-020-2540-y","article-title":"LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:59:35Z","timestamp":1779533975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"alternative-id":["S0304383526002089"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218445","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218445"}}